FLG Mutations and Atopic Dermatitis
Contact
Description
The primary objective is to confirm the association of the Filament-AggregatingProtein loss-of-function mutations with respect to the severity of disease (its persistence) and its association with components of the atopic triad (i.e., seasonal allergy and asthma) within our AtopicDermatitis cohort.
Eligibility and criteria
IRB Number:
13-010266
Eligible age range:
Clinical trial phase:
N/A
Official title:
We need families like you
Your time and participation make a difference in supporting the work of the Research Institute and children in our community. Learn more about opportunities to participate in our research.